Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Clinical trial NCT01254188 · COMPLETED
Trial details
- NCT number
- NCT01254188
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2014-11-01
- Enrollment
- 421
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.